莱美药业(300006)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300006 莱美药业

已收盘 12-16 15:00:00

{"stockData":{"symbol":"300006","market":"SZ","secType":"STK","nameCN":"莱美药业","latestPrice":4.53,"timestamp":1765868583000,"preClose":4.71,"halted":0,"volume":28416286,"delay":0,"changeRate":-0.0382,"floatShares":1056000000,"shares":1056000000,"eps":-0.1017,"marketStatus":"已收盘","change":-0.18,"latestTime":"12-16 15:00:00","open":4.71,"high":4.74,"low":4.5,"amount":130000000,"amplitude":0.051,"askPrice":4.53,"askSize":970,"bidPrice":4.52,"bidSize":2144,"shortable":0,"etf":0,"ttmEps":-0.1017,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765935000000},"marketStatusCode":5,"adr":0,"adjPreClose":4.71,"symbolType":"stock","openAndCloseTimeList":[[1765848600000,1765855800000],[1765861200000,1765868400000]],"highLimit":5.18,"lowLimit":4.24,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":1055911205,"isCdr":false,"pbRate":2.7,"roa":"--","roe":"--","epsLYR":-0.0832,"committee":0.280141,"marketValue":4783000000,"turnoverRate":0.0269,"status":1,"floatMarketCap":4783000000},"requestUrl":"/m/hq/s/300006","defaultTab":"news","newsList":[{"id":"2591774606","title":"莱美药业：截至2025年12月10日股东户数为31,490","url":"https://stock-news.laohu8.com/highlight/detail?id=2591774606","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591774606?lang=zh_cn&edition=full","pubTime":"2025-12-16 15:09","pubTimestamp":1765868956,"startTime":"0","endTime":"0","summary":"证券之星消息，莱美药业(300006)12月16日在投资者关系平台上答复投资者关心的问题。投资者提问：截止12月9日，公司最新的股东户数是多少？莱美药业回复：尊敬的投资者，您好。截至2025年12月10日，公司股东户数为31,490。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121600019572.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0070","300006"],"gpt_icon":0},{"id":"2590736915","title":"莱美药业：截至2025年12月10日股东户数为31,490户","url":"https://stock-news.laohu8.com/highlight/detail?id=2590736915","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590736915?lang=zh_cn&edition=full","pubTime":"2025-12-12 15:03","pubTimestamp":1765522996,"startTime":"0","endTime":"0","summary":"证券之星消息，莱美药业(300006)12月12日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止 2025 年 12 月 10 日股东人数是多少？谢谢！莱美药业回复：答：尊敬的投资者您好。截至2025 年12 月10日，公司股东户数为31,490户。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121200018124.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0070","300006"],"gpt_icon":0},{"id":"2590582793","title":"莱美药业：积极评估AI在新药研发中的应用价值","url":"https://stock-news.laohu8.com/highlight/detail?id=2590582793","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590582793?lang=zh_cn&edition=full","pubTime":"2025-12-10 20:53","pubTimestamp":1765371183,"startTime":"0","endTime":"0","summary":"证券之星消息，莱美药业(300006)12月10日在投资者关系平台上答复投资者关心的问题。投资者提问：公司在药物筛选和临床上会使用或者引进AI智能化的辅助工具吗莱美药业回复：尊敬的投资者，您好！公司持续关注人工智能领域的前沿发展，积极评估其在新药研发、数据分析、流程优化等生产经营管理场景中的应用价值。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121000038003.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300006","BK0070","BK0239"],"gpt_icon":0},{"id":"2590530416","title":"莱美药业(300006.SZ)控股子公司取得两项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2590530416","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590530416?lang=zh_cn&edition=full","pubTime":"2025-12-10 16:11","pubTimestamp":1765354272,"startTime":"0","endTime":"0","summary":"智通财经APP讯，莱美药业(300006.SZ)公告，公司控股子公司海南莱美医疗器械有限公司(简称“莱美医疗器械”)收到海南省药品监督管理局颁发的两项《医疗器械注册证》，产品名称为：医用电子内窥镜图像处理器、电子支气管镜。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1379838.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","09997","09996","BK0070","BK1100","BK1574","BK0239","159883","BK1222","300006"],"gpt_icon":0},{"id":"2588001187","title":"莱美药业(300006.SZ)控股子公司获得药物临床试验批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2588001187","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588001187?lang=zh_cn&edition=full","pubTime":"2025-12-04 16:03","pubTimestamp":1764835400,"startTime":"0","endTime":"0","summary":"智通财经APP讯，莱美药业(300006.SZ)发布公告，近日，公司控股子公司四川瀛瑞医药科技有限公司(简称“瀛瑞医药”)自主研发的创新抗癌药物“纳米炭铁混悬注射液”(简称“纳米炭铁”)获国家药品监督管理局签发《药物临床试验批准通知书》，同意纳米炭铁联合标准放疗在实体瘤患者中开展临床试验。本次获批的临床试验将进一步验证“纳米炭铁+放疗”联合方案的安全性和潜在疗效，陆续在多个临床中心启动“纳米炭铁+放疗”研究，重点关注局部治疗难度较大的实体瘤，以期在确保安全性的前提下，进一步探索联合疗法的临床价值。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1377663.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"莱美药业(300006.SZ)控股子公司获得药物临床试验批准通知书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0070","BK0239","300006"],"gpt_icon":0},{"id":"2588009564","title":"莱美药业：截至2025年11月28日股东户数为33,303","url":"https://stock-news.laohu8.com/highlight/detail?id=2588009564","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588009564?lang=zh_cn&edition=full","pubTime":"2025-12-04 15:36","pubTimestamp":1764833785,"startTime":"0","endTime":"0","summary":"证券之星消息，莱美药业(300006)12月04日在投资者关系平台上答复投资者关心的问题。投资者提问：截止2025年11月28日，公司最新股东户数？莱美药业回复：尊敬的投资者，您好。截至2025年11月28日，公司股东户数为33,303。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120400018515.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300006","BK0070","BK0239"],"gpt_icon":0},{"id":"2586223207","title":"莱美药业（300006）披露获得药品补充申请批准通知书，11月27日股价下跌2.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586223207","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586223207?lang=zh_cn&edition=full","pubTime":"2025-11-27 22:08","pubTimestamp":1764252506,"startTime":"0","endTime":"0","summary":"截至2025年11月27日收盘，莱美药业报收于5.27元，较前一交易日下跌2.41%，最新总市值为55.65亿元。公司近日发布公告称，重庆莱美药业股份有限公司收到国家药品监督管理局核准签发的注射用氨曲南《药品补充申请批准通知书》，通过仿制药质量和疗效一致性评价，并获准变更药品质量标准、直接接触药品的包装材料和容器。有效期为12个月，上市许可持有人应在批准之日起6个月内实施变更。截至目前，国内已有12家企业通过一致性评价。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112700038220.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","300006","BK0239"],"gpt_icon":0},{"id":"2586022891","title":"莱美药业：获得药品补充申请批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2586022891","media":"证券日报 ","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586022891?lang=zh_cn&edition=full","pubTime":"2025-11-27 20:09","pubTimestamp":1764245340,"startTime":"0","endTime":"0","summary":"郑重声明：东方财富发布此内容旨在传播更多信息，与本站立场无关，不构成投资建议。据此操作，风险自担。                                        \n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-27/doc-infywcvv9934788.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-27/doc-infywcvv9934788.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","300006","BK0070"],"gpt_icon":0},{"id":"2586024587","title":"莱美药业最新公告：注射用氨曲南通过仿制药注射剂一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2586024587","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586024587?lang=zh_cn&edition=full","pubTime":"2025-11-27 17:13","pubTimestamp":1764234784,"startTime":"0","endTime":"0","summary":"莱美药业(300006.SZ)公告称，公司收到国家药品监督管理局核准签发的注射用氨曲南（规格：0.5g）《药品补充申请批准通知书》。该药品通过仿制药注射剂一致性评价，并同意变更药品质量标准和直接接触药品的包装材料和容器。注射用氨曲南适用于治疗敏感革兰氏阴性菌引起的感染。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112700024900.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0070","300006"],"gpt_icon":0},{"id":"2586987428","title":"莱美药业：截至2025年11月20日股东户数为30,614","url":"https://stock-news.laohu8.com/highlight/detail?id=2586987428","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586987428?lang=zh_cn&edition=full","pubTime":"2025-11-25 16:31","pubTimestamp":1764059470,"startTime":"0","endTime":"0","summary":"证券之星消息，莱美药业(300006)11月25日在投资者关系平台上答复投资者关心的问题。投资者提问：请问11月20日的股东人数多少，谢谢莱美药业回复：尊敬的投资者，您好。截至2025年11月20日，公司股东户数为30,614。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112500021727.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0070","300006"],"gpt_icon":0},{"id":"2584360947","title":"莱美药业：公司中选药品的销售额可通过米内网等专业医药数据平台查询","url":"https://stock-news.laohu8.com/highlight/detail?id=2584360947","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584360947?lang=zh_cn&edition=full","pubTime":"2025-11-19 21:35","pubTimestamp":1763559300,"startTime":"0","endTime":"0","summary":"证券日报网讯莱美药业11月19日在互动平台回答投资者提问时表示，公司中选药品的销售额可通过米内网等专业医药数据平台查询。（文章来源：证券日报）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-19/doc-infxyazr3411298.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-19/doc-infxyazr3411298.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","BK0070","09939","159938","300006","BK1515","BK1574","BK1161"],"gpt_icon":0},{"id":"2584960329","title":"莱美药业：与奥信阳光未签署丁苯酞正式协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2584960329","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584960329?lang=zh_cn&edition=full","pubTime":"2025-11-19 08:36","pubTimestamp":1763512573,"startTime":"0","endTime":"0","summary":"证券之星消息，莱美药业11月18日在投资者关系平台上答复投资者关心的问题。公司与奥信阳光于2021年9月签署了《项目收购意向协议》，后续未签署正式协议。若后续有相关进展，公司将根据深圳证券交易所相关规则及时履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111900005643.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","300006","BK0239"],"gpt_icon":0},{"id":"2584677219","title":"莱美药业：主要聚焦抗肿瘤、消化系统等领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2584677219","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584677219?lang=zh_cn&edition=full","pubTime":"2025-11-19 08:33","pubTimestamp":1763512393,"startTime":"0","endTime":"0","summary":"证券之星消息，莱美药业(300006)11月18日在投资者关系平台上答复投资者关心的问题。投资者提问：公司正在积极寻求药物的引进和相关的合作，请问公司重点关注哪些方向？莱美药业回复：尊敬的投资者您好。公司主要聚焦抗肿瘤、消化系统及其他特色专科药物等相关领域。感谢您的关注!以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111900005630.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0239","300006"],"gpt_icon":0},{"id":"2584540229","title":"股市必读：莱美药业（300006）11月18日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2584540229","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584540229?lang=zh_cn&edition=full","pubTime":"2025-11-19 01:09","pubTimestamp":1763485755,"startTime":"0","endTime":"0","summary":"截至2025年11月18日收盘，莱美药业报收于5.22元，下跌3.87%，换手率4.27%，成交量45.06万手，成交额2.38亿元。董秘最新回复投资者： 中恒集团公开征集转让莱美药业23.43%股份事项是否还在继续？公司将持续关注控股股东所持公司股份公开征集转让事宜。如有进展，公司将根据深交所相关规则及时披露进展公告。当日关注点来自交易信息汇总：11月18日主力资金净流出4728.81万元，散户资金净流入4008.5万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111900000668.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","300006","BK0239"],"gpt_icon":0},{"id":"2580050262","title":"莱美药业：截至2025年10月31日股东户数为35,408","url":"https://stock-news.laohu8.com/highlight/detail?id=2580050262","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580050262?lang=zh_cn&edition=full","pubTime":"2025-11-03 16:30","pubTimestamp":1762158653,"startTime":"0","endTime":"0","summary":"证券之星消息，莱美药业(300006)11月03日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好！请问截止10月31日公司的股东人数是多少？谢谢莱美药业回复：尊敬的投资者，您好。截至2025年10月31日，公司股东户数为35,408。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110300021521.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300006","BK0239","BK0070"],"gpt_icon":0},{"id":"2579110363","title":"中恒集团最新公告：控股子公司莱美药业产品尼可地尔片拟中选第十一批全国药品集中采购","url":"https://stock-news.laohu8.com/highlight/detail?id=2579110363","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579110363?lang=zh_cn&edition=full","pubTime":"2025-10-30 19:02","pubTimestamp":1761822123,"startTime":"0","endTime":"0","summary":"中恒集团(600252.SH)公告称，公司控股子公司莱美药业参加了第十一批全国药品集中采购并拟中选尼可地尔片，该产品尚未开展销售。若后续签订采购合同并实施，将促进产品销售和市场拓展，提升公司品牌影响力，对长远发展有积极影响。但中标结果和采购合同签订存在不确定性，且药品生产和销售受多种因素影响，投资者需谨慎决策并注意投资风险。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000039276.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","600252","BK0188","BK0028","BK0015","BK0070","300006","BK0077","BK0239"],"gpt_icon":0},{"id":"2577310358","title":"莱美药业（300006）2025年三季报简析：净利润同比下降73.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577310358","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577310358?lang=zh_cn&edition=full","pubTime":"2025-10-23 06:04","pubTimestamp":1761170672,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期莱美药业发布2025年三季报。根据财报显示，莱美药业净利润同比下降73.82%。截至本报告期末，公司营业总收入5.81亿元，同比下降4.06%，归母净利润-4591.72万元，同比下降73.82%。按单季度数据看，第三季度营业总收入2.04亿元，同比下降8.95%，第三季度归母净利润-1453.99万元，同比上升47.59%。本次财报公布的各项数据指标表现不尽如人意。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102300004106.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300006"],"gpt_icon":0},{"id":"2577823161","title":"莱美药业(300006.SZ)发布前三季度业绩，归母净亏损4591.72万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2577823161","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577823161?lang=zh_cn&edition=full","pubTime":"2025-10-21 17:39","pubTimestamp":1761039548,"startTime":"0","endTime":"0","summary":"智通财经APP讯，莱美药业(300006.SZ)发布2025年三季度报告，该公司前三季度营业收入为5.81亿元，同比减少4.06%。归属于上市公司股东的净亏损为4591.72万元。归属于上市公司股东的扣除非经常性损益的净亏损为4837.9万元。基本每股亏损为0.0435元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1357620.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"莱美药业(300006.SZ)发布前三季度业绩，归母净亏损4591.72万元","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0070","BK0239","300006"],"gpt_icon":0},{"id":"2575410712","title":"股市必读：10月10日莱美药业发布公告，股东减持0.59万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2575410712","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575410712?lang=zh_cn&edition=full","pubTime":"2025-10-13 05:11","pubTimestamp":1760303476,"startTime":"0","endTime":"0","summary":"来自股本股东变化：截至2025年9月30日，莱美药业股东户数环比下降0.95%，户均持股数量上升至3.0万股。股本股东变化股东增减持10月10日莱美药业发布公告，股东邱宇于2025年7月10日至2025年10月9日期间合计减持0.59万股，占公司总股本的0.0006%，期间股价上涨9.79%，截至10月9日收盘价为4.26元。截至2025年9月30日，公司股东户数为35,189。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101300001809.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0239","300006"],"gpt_icon":0},{"id":"2574128717","title":"莱美药业：截至2025年9月30日股东户数为35,189","url":"https://stock-news.laohu8.com/highlight/detail?id=2574128717","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574128717?lang=zh_cn&edition=full","pubTime":"2025-10-10 16:00","pubTimestamp":1760083232,"startTime":"0","endTime":"0","summary":"证券之星消息，莱美药业(300006)10月10日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止2025年9月30日公司股东人数有多少？谢谢莱美药业回复：尊敬的投资者，您好。截至2025年9月30日，公司股东户数为35,189。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101000022981.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300006","BK0070","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1765871680948,"stockEarnings":[{"period":"1week","weight":-0.0907},{"period":"1month","weight":-0.1245},{"period":"3month","weight":0.0086},{"period":"6month","weight":0.2695},{"period":"1year","weight":-0.1935},{"period":"ytd","weight":0.2869}],"compareEarnings":[{"period":"1week","weight":-0.0143},{"period":"1month","weight":-0.0307},{"period":"3month","weight":0.0016},{"period":"6month","weight":0.1414},{"period":"1year","weight":0.1403},{"period":"ytd","weight":0.154}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"重庆莱美药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"31490人(较上一季度减少5.44%)","perCapita":"33528股","listingDate":"2009-10-30","address":"重庆市南岸区玉马路99号","registeredCapital":"105591万元","survey":"　　重庆莱美药业股份有限公司的主营业务是医药制造。公司的主要产品是抗肿瘤药、消化系统药、肠外营养药、抗感染类。公司产品获得“2021年中国产学研合作创新与促进奖”、获得“2022年福建省科学技术进步一等奖”等多项荣誉称号。","listedPrice":16.5},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"莱美药业(300006)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供莱美药业(300006)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"莱美药业,300006,莱美药业股票,莱美药业股票老虎,莱美药业股票老虎国际,莱美药业行情,莱美药业股票行情,莱美药业股价,莱美药业股市,莱美药业股票价格,莱美药业股票交易,莱美药业股票购买,莱美药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"莱美药业(300006)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供莱美药业(300006)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}